Category: Life Sciences
Life Sciences market research reports by Plunkett Research, Ltd.
-
Enanta Pharmaceuticals Inc (ENTA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Enanta Pharmaceuticals Inc (ENTA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Enanta Pharmaceuticals Inc (ENTA:NAS) compared to its top competitors and ... Read More
-
Protagonist Therapeutics (PTGX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Protagonist Therapeutics (PTGX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Protagonist Therapeutics (PTGX:NAS) compared to its top competitors and comp ... Read More
-
vTv Therapeutics (VTVT:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
vTv Therapeutics (VTVT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for vTv Therapeutics (VTVT:NAS) compared to its top competitors and compared to the aver ... Read More
-
Elanco Animal Health Incorporated (ELAN:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Elanco Animal Health Incorporated (ELAN:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Elanco Animal Health Incorporated (ELAN:NYS) compared to its top co ... Read More
-
Syros Pharmaceuticals (SYRS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Syros Pharmaceuticals (SYRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Syros Pharmaceuticals (SYRS:NAS) compared to its top competitors and compared t ... Read More
-
Catalyst Pharmaceutical Inc (CPRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Catalyst Pharmaceutical Inc (CPRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Catalyst Pharmaceutical Inc (CPRX:NAS) compared to its top competitors an ... Read More
-
Sonoma Pharmaceuticals Inc (SNOA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Sonoma Pharmaceuticals Inc (SNOA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Sonoma Pharmaceuticals Inc (SNOA:NAS) compared to its top competitors and ... Read More
-
Heron Therapeutics Inc (HRTX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Heron Therapeutics Inc (HRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Heron Therapeutics Inc (HRTX:NAS) compared to its top competitors and compared ... Read More
-
Infinity Pharmaceuticals Inc (INFI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Infinity Pharmaceuticals Inc (INFI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Infinity Pharmaceuticals Inc (INFI:NAS) compared to its top competitors ... Read More
-
Biogen Inc (BIIB:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Biogen Inc (BIIB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Biogen Inc (BIIB:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Aclaris Therapeutics Inc (ACRS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Aclaris Therapeutics Inc (ACRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Aclaris Therapeutics Inc (ACRS:NAS) compared to its top competitors and comp ... Read More
-
Mersana Therapeutics (MRSN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Mersana Therapeutics (MRSN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Mersana Therapeutics (MRSN:NAS) compared to its top competitors and compared to ... Read More
-
Rigel Pharmaceuticals Inc (RIGL:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Rigel Pharmaceuticals Inc (RIGL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Rigel Pharmaceuticals Inc (RIGL:NAS) compared to its top competitors and co ... Read More
-
Elite Pharmaceuticals Inc (ELTP:PINX): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Elite Pharmaceuticals Inc (ELTP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Elite Pharmaceuticals Inc (ELTP:PINX) compared to its top competitors and ... Read More
-
NovaBay Pharmaceuticals Inc (NBY:ASE): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
NovaBay Pharmaceuticals Inc (NBY:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for NovaBay Pharmaceuticals Inc (NBY:ASE) compared to its top competitors and ... Read More
-
Xeris Pharmaceuticals Inc (XERS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Xeris Pharmaceuticals Inc (XERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Xeris Pharmaceuticals Inc (XERS:NAS) compared to its top competitors and co ... Read More
-
Gilead Sciences Inc (GILD:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Gilead Sciences Inc (GILD:NAS) compared to its top competitors and compared to th ... Read More
-
West Pharmaceutical Services Inc (WST:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
West Pharmaceutical Services Inc (WST:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for West Pharmaceutical Services Inc (WST:NYS) compared to its top compet ... Read More
-
Petros Pharmaceuticals Inc (PTPI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Petros Pharmaceuticals Inc (PTPI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Petros Pharmaceuticals Inc (PTPI:NAS) compared to its top competitors and ... Read More
-
VBI Vaccines Inc (VBIV:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
VBI Vaccines Inc (VBIV:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for VBI Vaccines Inc (VBIV:NAS) compared to its top competitors and compared to the aver ... Read More
-
Geron Corporation (GERN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Geron Corporation (GERN:NAS) compared to its top competitors and compared to the av ... Read More
-
Johnson and Johnson (JNJ:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Johnson and Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Johnson and Johnson (JNJ:NYS) compared to its top competitors and compared to the ... Read More
-
Adamis Pharmaceuticals Corporation (ADMP:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Adamis Pharmaceuticals Corporation (ADMP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Adamis Pharmaceuticals Corporation (ADMP:NAS) compared to its top ... Read More
-
Acorda Therapeutics Inc (ACOR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Acorda Therapeutics Inc (ACOR:NAS) compared to its top competitors and compar ... Read More
-
United Therapeutics Corporation (UTHR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for United Therapeutics Corporation (UTHR:NAS) compared to its top compet ... Read More
Research Assistance
